跳至主要内容
临床试验/NCT01255982
NCT01255982已完成不适用

Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up

AstraZeneca1 个研究点 分布在 1 个国家目标入组 249 人开始时间: 2011年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
249
试验地点
1
主要终点
Difference between basal and final Functional Assessment Staging (FAST) score to evaluate the functional change

研究概览

简要总结

This study aims to study prospectively for 8 months a sample of bipolar patients with acute depressive episode in order to identify that factors associated with functional impairment, with especial attention to the presence of subsyndromal symptoms beyond the acute phase.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Bipolar Disorder I or II (DSM-IV-TR)
  • Acute depressive episode at inclusion

排除标准

  • Inability (in investigator´s opinion) to carry out the follow-up plan
  • Patients participating or having participated within previous 6 months, in clinical trials
  • Mental retardation or any other medical condition affecting cognitive performance

结局指标

主要结局

Difference between basal and final Functional Assessment Staging (FAST) score to evaluate the functional change

时间窗: Range of Days 0-3

次要结局

  • FAST score to estimate the proportion of patients that not achieve functional remission(Range of Days 0-3)
  • Test Screen for Cognitive Impairment in Psychiatry (SCIP) to evaluate cognitive impairment both in the depressive phase and during clinical remission(Range of Days 0-3)
  • Mood chart (self-report)(Range of Days 0-3)
  • The presence of subsyndromal symptoms after the acute depressive phase using Montgomery-Asberg Depression Rating Scale (MADRS), Young Mania Rating Scale (YMRS), Diagnostic and Statistical Manual of Mental disorders (DSM-IV-TR)(Range of Days 0-3)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验